Amy Simon - Mar 31, 2023 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role: Chief Medical Officer
Signature: By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol: BEAM
Transactions as of: Mar 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/31/2023, 07:47 PM
Previous filing: Mar 27, 2023
Next filing: Apr 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BEAM	Common Stock	Award	$0	+20K	+30.71%	$0.00	85.1K	Mar 31, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.

Content

Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal annual installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.